H

Hengrui Medicine

Lianyungang, China Founded 1970 SSE: 600276
Nanomedicine Cancer Nanotherapy Drug Delivery Nanobiosensors Nanobiomarkers Regenerative Medicine

About

Leading Chinese pharma with nanomedicine oncology programs

Company Details

Type
public
Employees
25000+
Funding
Public

Key Products

  • Camrelizumab
  • Apatinib
Visit Website

Related Companies

N

Nanosphere (Luminex)

Northbrook, United States

N

NanoString Technologies

Seattle, United States

N

Nanobiotix

Paris, France

A

Arrowhead Research

Pasadena, United States